Capital Research Global Investors - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q4 2016$20,742,000
-77.2%
1,244,300
-71.9%
0.01%
-76.7%
Q3 2016$91,033,000
-60.2%
4,423,358
-40.9%
0.03%
-61.5%
Q2 2016$228,953,000
-29.0%
7,482,135
-13.2%
0.08%
-29.7%
Q1 2016$322,678,000
-15.7%
8,620,839
-2.8%
0.11%
-15.3%
Q4 2015$382,960,000
+14.3%
8,873,032
-0.8%
0.13%
+9.2%
Q3 2015$335,098,000
+10.3%
8,940,7020.0%0.12%
+20.0%
Q2 2015$303,894,000
-4.0%
8,940,7020.0%0.10%
-7.4%
Q1 2015$316,501,000
+3.9%
8,940,7020.0%0.11%
+4.9%
Q4 2014$304,520,000
-11.6%
8,940,702
+0.1%
0.10%
-13.4%
Q3 2014$344,563,000
+1.6%
8,933,434
+2.5%
0.12%0.0%
Q2 2014$339,289,000
+17.7%
8,717,609
+3.4%
0.12%
+14.4%
Q1 2014$288,200,000
+80.2%
8,429,358
+10.6%
0.10%
+76.3%
Q4 2013$159,970,000
+18.7%
7,624,885
+32.9%
0.06%
+11.3%
Q3 2013$134,813,000
+85.8%
5,736,700
+112.4%
0.05%
+71.0%
Q2 2013$72,573,0002,700,9000.03%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 2,750,000$75,900,0002.61%
PFM Health Sciences, LP 2,025,681$55,909,0001.90%
Tieton Capital Management, LLC 118,456$3,269,0001.83%
Altium Capital Management LP 190,000$5,244,0001.45%
DISCIPLINED GROWTH INVESTORS INC /MN 1,846,490$50,963,0001.03%
EARNEST PARTNERS LLC 6,316,365$174,332,0001.01%
Glenview Capital Management 1,679,747$46,361,0000.99%
Zebra Capital Management LLC 14,209$392,0000.63%
AIMZ Investment Advisors, LLC 44,185$1,220,0000.48%
Phocas Financial Corp. 132,101$3,646,0000.46%
View complete list of MYRIAD GENETICS INC shareholders